What is ResMed's stock issuance proceeds?

ResMed (RMD) reported stock issuance proceeds of $7.43M in Q1 2026.

How has ResMed's stock issuance proceeds changed year-over-year?

ResMed's stock issuance proceeds decreased by 17.7% year-over-year, from $9.02M to $7.43M.

What is the long-term trend for ResMed's stock issuance proceeds?

Over 3 years (2022 to 2025), ResMed's stock issuance proceeds has grown at a 16.2% compound annual growth rate (CAGR), from $47.38M to $74.44M.

What does stock issuance proceeds mean?

Cash received from issuing common stock — IPOs, secondary offerings, DRIP, employee stock purchase plans, and option exercises.

ResMed RMD Stock Issuance Proceeds

Stock Issuance Proceeds at other companies

InogenINGN

$27.21M—

Inspire Medical SystemsINSP

$109K-98.3%

Viemed Healthcare, Inc.VMD

$526K+4,682%

Pulmonx CorporationLUNG

$40K-63.6%

MedtronicMDT

$97M-10.2%

InsmedINSM

$30.31M+2.1%

Other financials

Income statement

See full

Revenue$1.4B+10.8%

Gross profit$891.0M+16.3%

Operating income$499.8M+17.3%

Net income$398.7M+9.2%

EPS (diluted)$2.74+10.5%

Balance sheet

See full

Cash & equivalents$1.7B+78.0%

Total debt$1.1B+29.8%

Total equity$6.5B+17.1%

Total assets$8.8B+16.1%

Cash flow

See full

Operating cash flow$554.1M-4.2%

CapEx$33.7M+61.8%

Free cash flow$520.5M-6.7%

Valuation

See full

Market cap$28.27B-19.1%

Enterprise value$27.71B-19.8%

P/E18.6×-6.3×

P/S5.1×-1.7×

Profitability

See full

Gross margin61.6%+2.8pp

Operating margin34.2%+2.1pp

Net margin27.4%+1.3pp

FCF margin31.7%+0.4pp

Returns & leverage

See full

Return on equity25.2%-0.6pp

Debt / equity0.2×0.0×

Current ratio3×-0.4×

Where this comes from

Reported directly by ResMed in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromIssuanceOfCommonStock.

The official record: ResMed’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about ResMed's stock issuance proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is ResMed's stock issuance proceeds?: ResMed (RMD) reported stock issuance proceeds of $7.43M in Q1 2026.
How has ResMed's stock issuance proceeds changed year-over-year?: ResMed's stock issuance proceeds decreased by 17.7% year-over-year, from $9.02M to $7.43M.
What is the long-term trend for ResMed's stock issuance proceeds?: Over 3 years (2022 to 2025), ResMed's stock issuance proceeds has grown at a 16.2% compound annual growth rate (CAGR), from $47.38M to $74.44M.
What does stock issuance proceeds mean?: Cash received from issuing common stock — IPOs, secondary offerings, DRIP, employee stock purchase plans, and option exercises.